Select a letter below to browse by last name or type
0-9 A B C D E F G H I J K L M N O P Q R S T U V W X Y Z

Showing results 24 to 43 of 50 < previous   next >
Issue DateTitleAuthor(s)
2008IFN-γ mediates the rejection of haematopoietic stem cells in IFN-γR1-deficient hostsRottman M.; Soudais C.; Vogt G.; Renia L. ; Emile J.-F.; Decaluwe H.; Gaillard J.-L.; Casanova J.-L.
2018In silico epitope mapping and experimental evaluation of the Merozoite Adhesive Erythrocytic Binding Protein (MAEBL) as a malaria vaccine candidateCravo, P; Machado, R.B; Leite, J.A; Leda, T; Suwanarusk, R; Bittencourt, N; Albrecht, L; Judice, C; Lopes, S.C.P; Lacerda, M.V.G; Ferreira, M.U; Soares, I.S; Goh, Y.S; Bargieri, D.Y; Nosten, F; Russell, B; Rénia, L ; Costa, F.T.M
2017In vivo and in vitro activities and ADME-tox profile of a quinolizidine-modified 4-aminoquinoline: A potent anti-P. falciparum and Anti-P. vivax blood-stage antimalarialBasilico, N; Parapini, S; Sparatore, A; Romeo, S; Misiano, P; Vivas, L; Yardley, V; Croft, S.L; Habluetzel, A; Lucantoni, L; Renia, L ; Russell, B; Suwanarusk, R; Nosten, F; Dondio, G; Bigogno, C; Jabes, D; Taramelli, D
2014Interferons and interferon regulatory factors in malariaGun, Sin Yee; Claser, Carla; Tan, Kevin Shyong Wei ; Renia, Laurent Claude Stephane 
2015Loss of TLR3 aggravates CHIKV replication and pathology due to an altered virus-specific neutralizing antibody responseHer, Z; Teng, T.-S; Tan, J.J.L; Teo, T.-H; Kam, Y.-W; Lum, F.-M; Lee, W.W.L; Gabriel, C; Melchiotti, R; Andiappan, A.K; Lulla, V; Lulla, A; Win, M.K; Chow, A ; Biswas, S.K ; Leo, Y.-S ; Lecuit, M; Merits, A; Rénia, L ; Ng, L.F.P 
2016Malaria parasites: The great escapeRénia, L ; Goh, Y.S
2015Methylene blue inhibits the asexual development of vivax malaria parasites from a region of increasing chloroquine resistanceSuwanarusk, R.; Russell, B. ; Ong, A.; Sriprawat, K.; Chu, C.S.; Pyaephyo, A.; Malleret, B. ; Nosten, F.; Renia, L. 
2016Mice lacking Programmed cell death-1 show a role for CD8 + T cells in long-term immunity against blood-stage malariaHorne-Debets, J.M; Karunarathne, D.S; Faleiro, R.J; Poh, C.M; Renia, L ; Wykes, M.N
2018Multimodal assessments of Zika virus immune pathophysiological responses in marmosetsLum, F.-M; Zhang, W; Lim, K.-C; Malleret, B ; Teo, T.-H; Koh, J.-J; Lee, K.J; Chua, T.-K; Kam, Y.-W; Yee, W.-X; Huen, I; Tan, J.J.L; Amrun, S.N; Prakash KN, B; Cozzone, P.J; Renia, L ; Lee, P.T.H; Ng, L.F.P 
2014Novel approaches to identify protective malaria vaccine candidatesChia, W.N ; Goh, Y.S; Rénia, L 
Feb-2010On the diversity of malaria parasites in African apes and the origin of Plasmodium falciparum from bonobosKrief, S.; Escalante, A.A.; Pacheco, M.A.; Mugisha, L.; André, C.; Halbwax, M.; Fischer, A.; Krief, J.-M.; Kasenene, J.M.; Crandfield, M.; Cornejo, O.E.; Chavatte, J.-M.; Lin, C.; Letourneur, F.; Grüner, A.C.; McCutchan, T.F.; Rénia, L. ; Snounou, G. 
2018Plasmodium co-infection protects against chikungunya virus-induced pathologiesTeo, T.-H; Lum, F.-M; Ghaffar, K; Chan, Y.-H; Amrun, S.N; Tan, J.J.L; Lee, C.Y.P; Chua, T.-K; Carissimo, G; Lee, W.W.L; Claser, C; Rajarethinam, R; Rénia, L ; Ng, L.F.P 
2005Practical PCR genotyping protocols for Plasmodium vivax using Pvcs and Pvmsp1Imwong, M; Pukrittayakamee, S; Grüner, A.C; Rénia, L ; Letourneur, F; Looareesuwan, S; White, N.J; Snounou, G
2015Preclinical assessment of viral vectored and protein vaccines targeting the Duffy-binding protein region II of Plasmodium vivaxde Cassan S.C.; Rushdi Shakri A.; Llewellyn D.; Elias S.C.; Cho J.S.; Goodman A.L.; Jin J.; Douglas A.D.; Suwanarusk R.; Nosten F.H.; Rénia L. ; Russell B. ; Chitnis C.E.; Draper S.J.
2018Prime-boost vaccination with recombinant protein and adenovirus-vector expressing Plasmodium vivax circumsporozoite protein (CSP) partially protects mice against Pb/Pv sporozoite challengeDe Camargo, T.M; De Freitas, E.O; Gimenez, A.M; Lima, L.C; De Almeida Caramico, K; Françoso, K.S; Bruna-Romero, O; Andolina, C; Nosten, F; Rénia, L ; Ertl, H.C.J; Nussenzweig, R.S; Nussenzweig, V; Rodrigues, M.M; Reyes-Sandoval, A; Soares, I.S
2016Rheopathologic Consequence of Plasmodium vivax Rosette FormationZhang R. ; Lee W.-C.; Lau Y.-L.; Albrecht L.; Lopes S.C.P.; Costa F.T.M.; Suwanarusk R.; Nosten F.; Cooke B.M.; Rénia L. ; Russell B. 
2017Safety and effectiveness of mass drug administration to accelerate elimination of artemisinin-resistant falciparum malaria: A pilot trial in four villages of Eastern MyanmarLandier, J; Kajeechiwa, L; Thwin, M.M; Parker, D.M; Chaumeau, V; Wiladphaingern, J; Imwong, M; Miotto, O; Patumrat, K; Duanguppama, J; Cerqueira, D; Malleret, B ; R‚nia, L ; Nosten, S; Von Seidlein, L; Ling, C; Proux, S; Corbel, V; Simpson, J.A; Dondorp, A.M; White, N.J; Nosten, F.H
2017Singapore's Anopheles sinensis Form A is susceptible to Plasmodium vivax isolates from the western Thailand-Myanmar borderPang, S.-C; Andolina, C; Malleret, B ; Christensen, P.R; Lam-Phua, S.-G; Razak, M.A.B.A; Chong, C.-S; Li, D ; Chu, C.S; Russell, B; Rénia, L ; Ng, L.-C; Nosten, F
2014Small molecule targeting malaria Merozoite surface protein-1 (MSP-1) prevents host invasion of divergent Plasmodial speciesChandramohanadas R.; Russell B. ; Liew K. ; Yau Y.H.; Chong A. ; Liu M. ; Gunalan K.; Raman R.; Renia L. ; Nosten F.; Shochat S.G.; Dao M.; Sasisekharan R.; Suresh S. ; Preiser P.
2015Spatiotemporal requirements for IRF7 in mediating type I IFN-dependent susceptibility to blood-stage Plasmodium infectionEdwards C.L.; Best S.E.; Gun, S.Y.; Claser C.; James K.R.; de Oca M.M.; Sebina I.; Rivera F.D.L.; Amante F.H.; Hertzog P.J.; Engwerda C.R.; Renia Laurent ; Haque A.